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Summary The frequency of DNA aneuploidy was investigated by flow cytometry in 156 colorectal adenomas
including 56 associated with 36 synchronous adenocarcinomas. Nine of 156 adenomas (6%) were DNA
aneuploid. DNA aneuploidy correlated with increasing size (P<0.005) and histopathological type (P<0.05)
but not with dysplasia. Adenomas in association with a synchronous adenocarcinoma did not have an
increased incidence of DNA aneuploidy. Adenocarcinomas found in association with adenomas tend to have
a lower incidence of DNA aneuploidy than the generality of colorectal cancers.
DNA aneuploidy as measured by flow cytometry is
present in about 60% of colorectal adeno-
carcinomas (Tribukait et al., 1983; Armitage et al.,
1985; Quirke et al., unpublished observations).
Early studies have suggested that aneuploidy is an
important new independent prognostic variable
unrelated to tumour grade or pathological stage
(Wolley et al., 1982; Armitage et al., 1985). Studies
in premalignant conditions such as long standing
ulcerative colitis (Hammarberg et al., 1984), cervical
intraepithelial neoplasia (Jakobsen et al., 1983) and
giant melanocytic naevi (Stenzinger et al., 1984)
have shown that DNA aneuploidy can arise prior
to the onset of invasive malignancy and as such
may be a sensitive early indicator of biological
aggressiveness. Recently, and after commencement
of our own work, Van den Ingh et al. (1985) and
Weiss et al. (1985) have demonstrated aneuploidy in
colorectal adenomas utilising fresh tissue. However,
they did not explore the relationship to
synchronous carcinoma.
The study reported here was undertaken to
establish the frequency of DNA aneuploidy in a
large series of colorectal adenomas and to relate
this to the currently accepted criteria of likely
malignant transformation: severe dysplasia,
histological type and size of adenoma. We have
also investigated whether or not there is a higher
incidence of DNA aneuploidy in adenomas found
in association with synchronous adenocarcinoma.
Materials and methods
Cases studied
One hundred and fifty-six colorectal adenomas
including 56 associated with 36 synchronous adeno-
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carcinomas were retrieved from the files of the
University Department of Pathology in Leeds.
Haematoxylin and eosin stained (5jim) sections of
each tumour were reviewed by a single pathologist.
The adenomas were graded as showing mild,
moderate or severe dysplasia and divided into
tubular, tubulovillous or villous type using accepted
criteria (Ekelund & Lindstrom, 1974; Kozuka, 1975;
and Konishi & Morson, 1982). The maximum dia-
meter of each tumour was measured from the slide
(Konishi & Morson, 1982) in order to eliminate
interobserver variation in the estimation of size
taken from the original gross descriptions. The
adenomas were grouped according to whether they
were <lcm, 1-2cm, or >2cm in diameter. The
colorectal carcinomas were graded into well,
moderate or poor histological differentiation using
accepted criteria (Grinnell, 1939).
Flow cytometry
Nuclear DNA measurements were performed using
a modification of the method of Hedley et al.
(1983). Fifty jim sections were cut from paraffin
embedded material and transferred to glass slides.
The sections were dewaxed in xylene and re-
hydrated by passing through a graded series of
alcohols: 100%, 95%, 90%, 70% and 50% and
washing twice in distilled water. The tissue was
removed from the slide with a scalpel and placed in
a test tube with 0.5% pepsin (Sigma Chemical
Company, Pool BH17 7NH) in 0.9% NaCl
adjusted to pH 1.5 with 2N HCI, and incubated at
37°C for 30min in a waterbath. After centrifuga-
fugation at 2000rpm, the pellet was washed twice in
distilled water and stained by suspending in a solu-
tion ( jigml-1) of 4'-6-diamidino-2- phenylindole-
dihydrochloride (Boehringer Mannheim, West
Germany) in RPMI 1640 tissue culture medium at
20°C for 30min before filtering through four layers
of butter muslin and syringing with a 23 gauge
needle. Samples were analysed on an EPICS V flow
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cytometer (Coulter Electronics, Hialeh, Florida,
USA). For excitation a Coherent Innova-90 5W UV
enhanced argon ion laser was used at 50mW at a
wavelength of 350nm.
A 408nm interference filter removed scattered
ultra-violet light. Ten thousand nuclei were counted.
DNA aneuploidy was defined as the presence of
more than one GO/Gl peak (Hiddemann et al., 1984).
Internal standards were not included for reasons
previously stated (Hedley et al., 1983, 1985). The
DNA index was calculated for DNA aneuploid
samples as being the ratio of the abnormal GO/G1
peak modal channel number to diploid GO/G1 peak
modal channel number. A ,standard programme
(Coulter Electronics, Hialeh, Florida, USA) was
used to calculate the half peak coefficient of
variation. The mean coefficient of variation was 7%.
Statistical analysis of the contingency tables was




The relationship between histological type, degree
of dysplasia and size for isolated adenomas and
those with synchronous carcinoma are shown in
Table I. Adenomas found in association with
adenocarcinomas differed in tending to be more
commonly smaller in size and of tubular type.
Eight of thirty-six adenocarcinomas (22%) were
graded as well differentiated, 17/36 (47%)
moderately well differentiated and 11/36 (31%)
poorly differentiated. There was no significant
correlation between histological grade of adeno-
carcinoma and grade of dysplasia (P=0.74), size
(P=0.09) or type (P=0.46) of synchronous
adenoma.
Flow cytometry
Of the 156 adenomas 9 (6%) were found to be
DNA aneuploid (see Figure 1). DNA aneuploidy
was significantly associated with the size and type
of adenoma but not with the degree of dysplasia
(see Table II). Size of adenoma was the most
significant factor with DNA aneuploidy being
present in none of <1.0cm, 4 (7%) of 1.0-2.0cm
and 5 (16%) of >2.0cm (P<0.005). Tubular
adenomas demonstrated the lowest incidence (2%)
with higher levels found in tubulo-villous (13%)
and villous adenomas (11%) (P<0.04).
Of the 36 adenocarcinomas, 12 (33%) were found
to be DNA aneuploid. No relationship was found
between histological grade and DNA aneuploidy or
the incidence of DNA aneuploidy in adenomas
associated with (4%) or without (7%) synchronous
adenocarcinoma. Of the two DNA aneuploid
Table I Pathological features of isolated adenomas and those with synchronous adenocarcinoma
Size Type Dysplasiaa
< I cm 1-2cm >2cm Tubular Tubulovillous Villous 1 2 3
Isolated adenomas 31 43 26 55 33 12 12 58 30
With synchronous
carcinoma 39 12 5 42 7 7 8 31 17
TOTAL 70 55 31 97 40 19 20 89 47
%TOTAL 45 35 20 62 26 12 13 57 30
al =mild; 2 =moderate; 3 =severe dysplasia.
Table II Histological features in diploid and DNA aneuploid adenomas
Size Type Dysplasia
< I cm 1-2cm >2cm Tubular Tubulovillous Villous 1 2 3
DNA CONTENT
Diploid 70 51 26 95 35 17 19 83 45
DNA aneuploid 0 4 5 2 5 2 1 6 2
%DNA ANEUPLOID 0 7 16 2 13 11 5 7 4
X2 = 10.63 X2 =6.57
P<0.005 P<0.05
X2 =0-37
P =0.83DNA ANEUPLOIDY IN COLORECTAL ADENOMAS
b
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Figure 1 Examples of histograms of DNA content in colorectal adenomas (a) DNA aneuploid (b) diploid.
adenomas associated with synchronous adeno-
carcinoma one occurred in association with a
diploid and the other a DNA aneuploid adeno-
carcinoma.
The DNA indices of DNA aneuploid adenomas
were widely distributed but appeared similar to the
DNA indices of a series of over 160 colorectal
adenocarcinomas measured in parallel (Quirke et al.,
unpublished observations).
Discussion
Routine pathological examination of colorectal
adenomas currently relies on assessments of tumour
size and histopathological type and the degree of
dysplasia present. However, interobserver variation
in the latter assessment almost negates its value in
routine use (Brown et al., 1985). Other factors
suggested to be of value in assessessing progression
in the adenoma-carcinoma sequence include ultra-
structural changes (Kaye et al., 1971; Fenoglio et
al., 1975), cell kinetic and pericryptal fibroblast
changes (Kaye et al., 1971), differences in mucin
(Filipe & Branfoot, 1976; Culling et al., 1977) and
lectin profiles (Boland et al., 1982), immunohisto-
chemistry (Rognum et al., 1982) and the
appearance of foetal blood group antigens (Cooper
et al., 1980). However, none of these have yet
proved of value in predicting the invasive potential
of adenomas.
Measurement of DNA aneuploidy by flow
cytometry is quantitative and reproducible.
Evidence is now accumulating that it is a marker of
poor prognosis in colorectal adenocarcinoma
(Wolley et al., 1982; Armitage et al., 1985) as well
as in tumours of ovary (Friedlander et al., 1984a),
breast (Friedlander et al., 1984b) and cervix
(Jakobsen et al., 1984). The demonstration of such
karyotypic progression in a small percentage of
adenomas as compared to the much higher level
seen in adenocarcinomas suggests it may be a
useful early marker of biological aggressiveness.
Support for this conclusion can be derived from
similar findings in previous studies on the
chromosomal constitution of adenomas and adeno-
carcinomas (Enterline & Arvan, 1967; Reichmann
et al., 1981) and the strong association between
DNA aneuploidy and size of adenoma and to a
lesser extent histopathological type. The highly
significant association between size and DNA
aneuploidy is important as size has been shown to
be an excellent predictor of the presence of
carcinomatous change in an adenoma (Muto et al.,
1975). Size is followed by histopathological type
and lastly the degree of dysplasia in predictive
ability.
Our findings are supported by those of van den
Ingh et al. (1985) who in a smaller series of 55
colorectal adenomas reported a significant
association between DNA aneuploidy and tumour
size. They did not however find any significant
association between the histopathological type of
adenoma or the degree of dysplasia and DNA
aneuploidy. These workers also found a
substantially higher percentage of DNA aneuploidy
(27% vs. 6%) than observed in this study. There
are three possible explanations for this discrepancy.
Firstly, they used fresh tissue in association with a
biological internal standard and defined DNA
aneuploidy in two ways: either when there were two
or more GO/G1 peaks (as used in this study) or
when the GO/G1: internal standard ratio was either
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second definition has been severely criticised in a
study of lymphomas (Shackney et al., 1984) and
has not been adopted in a recent international
report on nomenclature in DNA cytometry
(Hiddemann et al., 1984). Secondly, the observed
incidence of DNA aneuploidy is dependent upon
the technique of DNA staining employed and the
sensitivity of the flow cytometric measurements.
The latter is expressed by the coefficient of
variation (CV) of the GO/GI peak, the incidence of
DNA aneuploidy tending to increase with a
decreasing CV. In order to make meaningful
comparisons of flow cytometric data, CVs should
be stated (Hiddemann et al., 1984). In our
experience higher coefficients of variation are given
by archival paraffin embedded material than fresh
tissue and this may lead to a loss of resolution of
peridiploid peaks, but this does not outweigh the
usefulness of the technique (Hedley et al., 1985).
Thirdly, only 15% of their adenomas were <1 cm
in size as compared to a more representative 45%
in this series. Weiss et al. (1985) reported DNA
aneuploidy in 9% of their 58 non-malignant
adenomas. The histological assessments in this
study are open to criticism for three reasons.
Firstly, 30 of the 64 adenomas were designated to
be non-dysplastic, a contradiction in terms, as all
adenomas show at least mild dysplastic change
(Morson & Dawson, 1979). Secondly, they failed to
recognise any pure villous adenomas and finally
they did not measure the size of the adenomas, the
most important factor in assessing malignant
potential (Muto et al., 1975).
The relatively low incidence of DNA aneuploidy
found in adenomas when compared to carcinomas
probably reflects the long natural history of the
adenoma-carcinoma sequence which is considered
to take on average 10-15 years (Morson, 1974). It
is also of interest that comparison of isolated versus
cancer-associated adenomas, revealed no increase in
incidence of DNA aneuploidy in adenomas
associated with adenocarcinomas, and DNA
aneuploid adenocarcinomas were not found to be
associated with DNA aneuploid adenomas. It is
noteworthy also that the percentage of DNA
aneuploid adenocarcinomas in this study was low
(11/36:33%) as compared to the rate of 60% found
in over 160 colorectal adenocarcinomas measured
under exactly the same conditions in parallel studies
(Quirke et al., unpublished observations). Although
the numbers of synchronous adenocarcinomas
measured are small the increased incidence of
diploid carcinomas (67% vs. 40%) may reflect an
intrinsically longer natural history in such tumours,
allowing more time for adenomas to develop
synchronously within the surrounding colon.
It can be concluded that the use of DNA
measurements in colorectal adenomas allows identi-
fication of more biologically aggressive tumours
and indicates a group ofpatients who require closer
surveillance. However, the demonstration of
aneuploidy of itself will not identify all patients at
risk from the adenoma-carcinoma sequence since a
substantial proportion of colorectal adeno-
carcinomas are diploid (Rognum et al., 1982;
Tribukait et al., 1983; Quirke et al., -1985; Armitage
et al., 1985) and remain so throughout their natural
history (Rognum et al., 1985; Quirke et al., un-
published observations). To identify such cases
other techniques will require evaluation including
cell cycle analysis or a combination of flow
cytometric DNA measurements with antibodies to
oncogene products or cell surface receptors, or
fluorescent oncogene probes.
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